OptiBiotix Health Plc
Publication of third human study on LP-LDL
Sponsored Article
By Elric Langton | 18th January 2022
OptiBiotix Health plc (AIM: OPTI), a wholly-owned subsidiary, ProBiotix Health Ltd, has published a third human volunteer study on its cholesterol…